Search results
Results from the WOW.Com Content Network
Horizon Therapeutics plc was a biopharmaceutical company focused on researching, developing, ... Amgen acquired the company in October 2023. [5] History
Under the settlement terms with the FTC following its lawsuit to block the deal, Amgen is prevented from using anti-competitive tactics to extend the market dominance of Horizon's fast-growing ...
The U.S. Federal Trade Commission (FTC) has allowed Amgen to continue its $27.8 billion acquisition of Horizon Therapeutics, while preventing the drugmaker from using anticompetitive tactics to ...
The Federal Trade Commission will allow pharmaceutical giant Amgen to move ahead with its acquisition of Horizon Therapeutics, averting a trial set for September. Amgen settles with the FTC over ...
2023: Amgen completed the acquisition of Horizon Therapeutics in October 2023. [120] In December, announced plans to use artificial intelligence in partnership with Amazon Web Services to help discover and create medicines. [121] Amgen will use Amazon's SageMaker machine learning service to help with the manufacturing process. [121]
Amgen's acquisition of Horizon was the first biotech deal challenged since the FTC's 2021 launch of a pharmaceutical merger task force, which has been followed by workshops designed to explore ...
Rank Year Purchaser Target Value (in billions USD) Value (adjusted for inflation) 1 2015 Pfizer: Allergan, plc: 160 206 In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation).
(Reuters) -The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics, allowing the FTC to consider whether the agency should ...